https://charts.traderzeitung.de/phases/US1897632048 string(1419) "{"isin":"US1897632048","name":"Co-Diagnostics Inc","stock_id_xnas":132475387,"stock_id_xnys":132475388,"generated_at":"2026-09-24 01:31:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.08,"close_at":"2026-09-22 21:55:00","complete":true,"perf_pct":8},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":1.09,"close_at":"2026-09-22 22:03:00","complete":true,"perf_pct":0.9259}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":1.09,"close_at":"2026-09-23 14:52:00","complete":true,"perf_pct":0},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.09,"close_at":"2026-09-23 21:48:00","complete":true,"perf_pct":0},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

Co-Diagnostics Aktie News & Nachrichten

[WKN: A41UNJ | Symbol: CODX]

Realtimekurs

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Co-Diagnostics gefunden werden.

Co-Diagnostics Nachrichtenticker öffnen

MT Newswires 17.08.2026 13:54 Uhr

Co-Diagnostics Aktie News & Nachrichten

Artikel aus der Redaktion der Trader-Zeitung

--Maxim Group stuft Co-Diagnostics von Halten auf Kaufen hoch, Kursziel 4 USD

Indisches Joint-Venture von Co-Diagnostics startet klinische Studien für Tuberkulosetest

Co-Diagnostics unterzeichnet exklusiven Vertriebsvertrag mit mexikanischem Partner; Aktien steigen vorbörslich

Top-Mittagsgewinner